Equities

Polaris Group LLC

6550:TAI

Polaris Group LLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)55.90
  • Today's Change-0.40 / -0.71%
  • Shares traded917.25k
  • 1 Year change-32.81%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4,9477,3815,992
Total Receivables, Net250.525.35
Total Inventory36----
Prepaid expenses8815419
Other current assets, total8.565.16334
Total current assets5,1057,5406,350
Property, plant & equipment, net1,6011,5881,364
Goodwill, net2,066----
Intangibles, net400.170.38
Long term investments1816062
Note receivable - long term------
Other long term assets26237.86
Total assets9,0989,2197,822
LIABILITIES
Accounts payable2.14----
Accrued expenses10578114
Notes payable/short-term debt6750278
Current portion long-term debt/capital leases7212120
Other current liabilities, total1065225
Total current liabilities959251437
Total long term debt452262139
Total debt1,198383437
Deferred income tax------
Minority interest267----
Other liabilities, total543333
Total liabilities1,732545608
SHAREHOLDERS EQUITY
Common stock7,4387,4207,188
Additional paid-in capital11,69711,4769,824
Retained earnings (accumulated deficit)(12149)(10573)(9422)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total381350(376)
Total equity7,3668,6747,214
Total liabilities & shareholders' equity9,0989,2197,822
Total common shares outstanding744742719
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.